Clinical Trial Update: Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and feasibility of combining Argatroban, tissue plasminogen activator (alteplase), and intra-arterial therapy for acute st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Ischemia
• Stroke

Drugs mentioned

• Activase (alteplase)
• Argatroban (argatroban)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Stroke, Cerebral Ischemia | Phase 2 | Status: COMPLETED